Home › Research › Topics › protects
protects
4 studies tagged protects, dated 2003-11-01 to 2025-08-25. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Web-Based Assessment of Cognition and Dementia Risk Factors in Over 3000 Norwegian Adults Aged 50 Years and Older: Cross-Sectional PROTECT Norge Study 2025-08-25
- Does Soluble TREM2 Protect Against Alzheimer's Disease? 2022-01-28
- Anti-inflammatory treatment in AD mice protects against neuronal pathology 2009-08-10
Studies
4 studies carry this tag.
Date range
2003 to 2025
Top journals
- Experimental neurology 1
- Frontiers in aging neuroscience 1
- JMIR aging 1
- Journal of neurochemistry 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
These data show the associations between dementia risk factors and cognition and attest to the excellent feasibility of the PROTECT Norge cohort, with over 3000 participants included over a period of 2 years and accessibility for people with early cognitive impairment.
-
Triggering Receptor Expressed in Myeloid Cells 2 (TREM2) is a pattern recognition receptor on myeloid cells, and is upregulated on microglia surrounding amyloid plaques in Alzheimer's disease (AD).
-
Prior studies suggest that non-steroidal anti-inflammatory drugs (NSAIDs) may lower the incidence of Alzheimer's disease (AD) and delay onset or slow progression of symptoms in mouse models of AD.
-
Previously, we found that amyloid beta-protein (Abeta)1-42 exhibits neurotoxicity, while Abeta1-40 serves as an antioxidant molecule by quenching metal ions and inhibiting metal-mediated oxygen radical generation.